for oncology i have:
MSS-CRC enrolling thru april
MSS-CRC rollover w ICI, continuation of main trial
MSS-CRC conference abstracts AACR and probably ASCO
MSS-CRC liver mets pilot could be underway
TNBC updated protocol submission early 20206
TNBC conference abstracts AACR and ASCO
TNBC EAP should be underway
GBM pilot proposed, needs protocol
GBM pre-clinical completed, conference abstract AACR
OTHER:
JL also mentioned that they can continue to accept patients via the EIND (from that old basket study) for pancreatic / prostate / sarcoma / urothelial (bladder) cancers
https://www.youtube.com/watch?v=7ClOwe2Vjrw
minute 33
In that video, he talks about a proposed gbm pilot, but then says they want to give leronlimab to gbm patients with recurrent gbm and "absolutely no treatment options". That indicates compassionate use to me. so its tough to make sense of the status. seems like potentially 2 different programs, but hard to say. shareholder letter coming up might clarify that. I just can't find anything that sayd they have dosed any gbm patients since that guy everyone was following on instagram.